Literature DB >> 8823767

Demographics of brain metastasis.

J D Johnson1, B Young.   

Abstract

Brain metastases are the most common intracranial tumor, significantly out-numbering primary brain tumors. The apparent increase in the ratio of brain metastases to primary tumors may be the result of a number of factors, including the possibility of a CNS "pharmacologic sanctuary," an aging population, and improved imaging studies. Among adults, the most common origins of brain metastasis include primary tumors of the lung, breast, skin (melanoma), and gastrointestinal tract. Among patients under 21 years of age, brain metastases most often arise from the sarcomas and germ cell tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8823767

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  78 in total

1.  Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.

Authors:  Christos Christodoulou; Dimitrios Bafaloukos; Helen Linardou; Gerassimos Aravantinos; Aristotelis Bamias; Maria Carina; George Klouvas; Dimosthenis Skarlos
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

3.  Utility of administrative claims data for the study of brain metastases: a validation study.

Authors:  April F Eichler; Elizabeth B Lamont
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

Review 4.  Current management of metastatic brain disease.

Authors:  Tulika Ranjan; Lauren E Abrey
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Melanoma brain metastases and vemurafenib: need for further investigation.

Authors:  Nicole M Rochet; Roxana S Dronca; Lisa A Kottschade; Rahul N Chavan; Brian Gorman; Julie R Gilbertson; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

Review 6.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

7.  Metastatic primary pulmonary melanoma successfully treated with checkpoint inhibitors.

Authors:  Georges Al-Helou; Nardos Temesgen; Jonathan Gwizdala; Jalil Ahari
Journal:  BMJ Case Rep       Date:  2018-03-15

8.  Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain.

Authors:  Chenyu Zhang; Fahao Zhang; Rachel Tsan; Isaiah J Fidler
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

Review 9.  Brain metastases.

Authors:  Susan Lalondrelle; Vincent Khoo
Journal:  BMJ Clin Evid       Date:  2009-03-12

10.  Brain metastases admissions in Sweden between 1987 and 2006.

Authors:  K E Smedby; L Brandt; M L Bäcklund; P Blomqvist
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.